213 related articles for article (PubMed ID: 25752820)
1. Temperature-sensitive retinoid isomerase activity of RPE65 mutants associated with Leber Congenital Amaurosis.
Li S; Hu J; Jin RJ; Aiyar A; Jacobson SG; Bok D; Jin M
J Biochem; 2015 Aug; 158(2):115-25. PubMed ID: 25752820
[TBL] [Abstract][Full Text] [Related]
2. Rescue of enzymatic function for disease-associated RPE65 proteins containing various missense mutations in non-active sites.
Li S; Izumi T; Hu J; Jin HH; Siddiqui AA; Jacobson SG; Bok D; Jin M
J Biol Chem; 2014 Jul; 289(27):18943-56. PubMed ID: 24849605
[TBL] [Abstract][Full Text] [Related]
3. Functional Rescue of Retinal Degeneration-Associated Mutant RPE65 Proteins.
Jin M; Li S; Hu J; Jin HH; Jacobson SG; Bok D
Adv Exp Med Biol; 2016; 854():525-32. PubMed ID: 26427455
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
Li S; Samardzija M; Yang Z; Grimm C; Jin M
J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between fatty acid transport protein 4 and vision in Leber congenital amaurosis associated with RPE65 mutation.
Li S; Gordon WC; Bazan NG; Jin M
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32114-32123. PubMed ID: 33257550
[TBL] [Abstract][Full Text] [Related]
6. Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65.
Ripamonti C; Henning GB; Ali RR; Bainbridge JW; Robbie SJ; Sundaram V; Luong VA; van den Born LI; Casteels I; de Ravel TJ; Moore AT; Stockman A
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6817-28. PubMed ID: 25257057
[TBL] [Abstract][Full Text] [Related]
7. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium.
Jin M; Li S; Moghrabi WN; Sun H; Travis GH
Cell; 2005 Aug; 122(3):449-59. PubMed ID: 16096063
[TBL] [Abstract][Full Text] [Related]
8. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
Koenekoop RK; Sui R; Sallum J; van den Born LI; Ajlan R; Khan A; den Hollander AI; Cremers FP; Mendola JD; Bittner AK; Dagnelie G; Schuchard RA; Saperstein DA
Lancet; 2014 Oct; 384(9953):1513-20. PubMed ID: 25030840
[TBL] [Abstract][Full Text] [Related]
9. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635
[TBL] [Abstract][Full Text] [Related]
10. Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa.
Kiang AS; Kenna PF; Humphries MM; Ozaki E; Koenekoop RK; Campbell M; Farrar GJ; Humphries P
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33261050
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the RPE65 gene causing Leber congenital amaurosis and its transcriptional expression in vitro.
Mo G; Ding Q; Chen Z; Li Y; Yan M; Bu L; Song Y; Yin G
PLoS One; 2014; 9(11):e112400. PubMed ID: 25383945
[TBL] [Abstract][Full Text] [Related]
12. RPE65 Mutations in Two Japanese Families with Leber Congenital Amaurosis.
Katagiri S; Hayashi T; Kondo M; Tsukitome H; Yoshitake K; Akahori M; Ikeo K; Tsuneoka H; Iwata T
Ophthalmic Genet; 2016 Jun; 37(2):161-9. PubMed ID: 25495949
[TBL] [Abstract][Full Text] [Related]
13. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy.
Cideciyan AV
Prog Retin Eye Res; 2010 Sep; 29(5):398-427. PubMed ID: 20399883
[TBL] [Abstract][Full Text] [Related]
14. Cone-rod dystrophy caused by a novel homozygous RPE65 mutation in Leber congenital amaurosis.
Jakobsson C; Othman IS; Munier FL; Schorderet DF; Abouzeid H
Klin Monbl Augenheilkd; 2014 Apr; 231(4):405-10. PubMed ID: 24771178
[TBL] [Abstract][Full Text] [Related]
15. A Gene Scan Study of
Liu J; Bu J
Chin Med J (Engl); 2017 Nov; 130(22):2709-2712. PubMed ID: 29133760
[TBL] [Abstract][Full Text] [Related]
16. The Status of RPE65 Gene Therapy Trials: Safety and Efficacy.
Pierce EA; Bennett J
Cold Spring Harb Perspect Med; 2015 Jan; 5(9):a017285. PubMed ID: 25635059
[TBL] [Abstract][Full Text] [Related]
17. Novel RPE65 mutations associated with Leber congenital amaurosis in Chinese patients.
Xu F; Dong Q; Liu L; Li H; Liang X; Jiang R; Sui R; Dong F
Mol Vis; 2012; 18():744-50. PubMed ID: 22509104
[TBL] [Abstract][Full Text] [Related]
18. Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.
Roman AJ; Cideciyan AV; Schwartz SB; Olivares MB; Heon E; Jacobson SG
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1378-83. PubMed ID: 23341016
[TBL] [Abstract][Full Text] [Related]
19. Utility of In Vitro Mutagenesis of RPE65 Protein for Verification of Mutational Pathogenicity Before Gene Therapy.
Yang U; Gentleman S; Gai X; Gorin MB; Borchert MS; Lee TC; Villanueva A; Koenekoop R; Maguire AM; Bennett J; Redmond TM; Nagiel A
JAMA Ophthalmol; 2019 Dec; 137(12):1381-1388. PubMed ID: 31580392
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of retinal molecular markers in the canine RPE65 model of Leber congenital amaurosis.
Hernández M; Pearce-Kelling SE; Rodriguez FD; Aguirre GD; Vecino E
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6793-802. PubMed ID: 20671290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
